Patent 7863453 was granted and assigned to Amicus Therapeutics on January, 2011 by the United States Patent and Trademark Office.
A novel tartaric acid salt of Isofagomine (Isofagomine tartrate) that can be used for the treatment of Gaucher disease is provided. The invention also provides a crystalline form of isofagomine tartrate, method for preparing the salt, a pharmaceutical composition containing the salt, and a method of treating Gaucher disease.